Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04AUA
|
||||
| Former ID |
DIB001385
|
||||
| Drug Name |
MIV-170
|
||||
| Synonyms |
MIV-140; MSK-076; Non-nucleoside reverse transcriptase inhibitors, Medivir; HIV polymerase inhibitors, Medivir/Bristol-Myers Squibb; NNRTIs (HIV infection), Medivir/Bristol-Myers Squibb
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] | Terminated | [547796] | ||
| Company |
Medivir AB
|
||||
| Formula |
C24H21F2N3O4S
|
||||
| Canonical SMILES |
O=S(=O)(c1ccc(Oc2cnc(NC(=O)N[C@@H]3[C@@H]4COc5c(ccc(c5[<br />C@H]34)F)F)cc2)cc1)N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | HIV reverse transcriptase | Target Info | Inhibitor | [531011] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.